Financhill
Sell
47

VRTX Quote, Financials, Valuation and Earnings

Last price:
$483.64
Seasonality move :
12.78%
Day range:
$480.42 - $487.93
52-week range:
$377.85 - $519.88
Dividend yield:
0%
P/E ratio:
26.10x
P/S ratio:
11.41x
P/B ratio:
7.59x
Volume:
1.2M
Avg. volume:
1.4M
1-year change:
15.28%
Market cap:
$124.5B
Revenue:
$11B
EPS (TTM):
-$2.20

Earnings Data

Next earnings date for VRTX
May 06
2025
Most recent earnings per share
$3.50
Missed by $0.52
(Feb 10/2025)
Consensus Estimate
$4.02
(Feb 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VRTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $2.9B -- -- $4.34 --
05/06/2025 Q1 $2.9B -- -- $4.31 --
02/10/2025 Q4 $2.8B $2.9B $3.50 $4.02 -$0.52
11/04/2024 Q3 $2.7B $2.8B $4.01 $4.13 -$0.12
08/01/2024 Q2 $2.7B $2.6B -$13.92 -$11.75 -$2.17
05/06/2024 Q1 $2.6B $2.7B $4.21 $4.06 $0.15
02/05/2024 Q4 $2.5B $2.5B $3.71 $4.09 -$0.38
11/06/2023 Q3 -- -- $3.97 $3.97 -$0.00
08/01/2023 Q2 -- -- $3.52 $3.88 -$0.36
05/01/2023 Q1 -- -- $2.69 $3.00 -$0.31
02/07/2023 Q4 -- -- $3.15 $3.51 -$0.36
10/27/2022 Q3 -- -- $3.59 $3.64 -$0.05
08/04/2022 Q2 -- -- $3.13 $3.50 -$0.37
05/05/2022 Q1 -- -- $2.96 $3.54 -$0.58
01/26/2022 Q4 -- -- $3.00 $3.29 -$0.29
11/02/2021 Q3 -- -- $3.28 $3.06 $0.22
07/29/2021 Q2 -- -- $0.26 $2.38 -$2.12
04/29/2021 Q1 -- -- $2.49 $2.69 -$0.20
02/01/2021 Q4 -- -- $2.30 $2.55 -$0.25
10/29/2020 Q3 -- -- $2.53 $2.33 $0.20
07/30/2020 Q2 -- -- $3.18 $2.08 $1.10
04/29/2020 Q1 -- -- $2.29 $1.85 $0.44
01/30/2020 Q4 -- -- $2.23 $1.22 $1.01
10/30/2019 Q3 -- -- $0.22 $1.16 -$0.94
07/31/2019 Q2 -- -- $1.26 $1.07 $0.19
04/30/2019 Q1 -- -- $1.14 $1.01 $0.13
02/05/2019 Q4 -- -- $1.30 $1.06 $0.24
10/24/2018 Q3 -- -- $1.09 $1.01 $0.08
07/25/2018 Q2 -- -- $0.94 $0.75 $0.19
04/26/2018 Q1 -- -- $0.76 $0.63 $0.13
01/31/2018 Q4 -- -- $0.61 $0.54 $0.07
10/25/2017 Q3 -- -- $0.53 $0.37 $0.16
07/26/2017 Q2 -- -- $0.39 $0.36 $0.03
04/27/2017 Q1 -- -- $1.33 $1.13 $0.20
01/25/2017 Q4 -- -- $0.13 -- --
10/25/2016 Q3 -- -- -- -- --
07/27/2016 Q2 -- -- -- -- --
04/27/2016 Q1 -- -- -- $0.04 --
01/27/2016 Q4 -- -- -- -- --
10/28/2015 Q3 -- -- -- -- --
07/29/2015 Q2 -- -- -- -- --

Vertex Pharmaceuticals Earnings Questions

  • How Much did Vertex Pharmaceuticals Generate in Revenue Last Quarter?

    Vertex Pharmaceuticals reported $2.9B worth of top line sales in its most recent quarter.

  • Did Vertex Pharmaceuticals Beat Earnings Last Quarter?

    Vertex Pharmaceuticals announced earnings per share of $3.50 which represents a miss of analyst forecast a $4.02 per share.

  • Is Vertex Pharmaceuticals Profitable?

    Vertex Pharmaceuticals reported $2.5B that represents $9.67 per share over the last quarter.

  • What is the Analyst Consensus for Vertex Pharmaceuticals EPS Next Year?

    Vertex Pharmaceuticals's earnings are forecast to decrease from -$2.08 per share to $0.49 per share next year representing a decrease of -96.5%.

  • When is Vertex Pharmaceuticals's Earnings Date?

    Vertex Pharmaceuticals's next earnings date is May 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Should I Buy Alcoa Stock?
Should I Buy Alcoa Stock?

Alcoa (AA) finds itself in an interesting position in early…

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
GATE alert for Apr 2

Marblegate Acquisition [GATE] is up 86.64% over the past day.

Buy
52
NUTX alert for Apr 2

Nutex Health [NUTX] is up 5.41% over the past day.

Buy
73
CORT alert for Apr 3

Corcept Therapeutics [CORT] is down 8.84% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock